US begins studying risk of allergic reactions to Moderna, Pfizer Covid-19 vaccines
The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to Covid-19 vaccines made by Moderna Inc and Pfizer Inc.